Article info

Download PDFPDF

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement
Free
  1. Correspondence to:
    Professor G Valesini
    Dipartimento di Clinica e Terapia Medica Applicata, Cattedra di Reumatologia, Università “La Sapienza”, V’le del Policlinico 155, 00161 Rome, Italy; guido.valesiniuniroma1.it
View Full Text

Citation

Alessandri C, Bombardieri M, Papa N, et al
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

Publication history

  • Accepted November 19, 2003
  • First published September 10, 2004.
Online issue publication 
September 10, 2004

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.